Program:
Friday, 07 March, 1997
Arrive in Banff. Check into room at Banff Springs Hotel.
7:00 p.m. Mount Stephen Hall
- Private Reception
Banquet to follow
Saturday, 08 March, 1997
7:00-8:00 a.m. Set up posters - Baron Shaughnessy Ballroom
8:00 am Welcome, Opening Remarks,
Description of Internet/CD Publishing Link, Introduction of Dr. Marovitz. .... Kim Solez
8:10 The Internet and Medical Publishing. . . . . William F.Marovitz, President and CEO, Churchill Livingstone International
8:40 Discussion
8:50 Transplant Pathology Internet Services (TPIS) resource and relation to Banff meeting (http://tpis.upmc.edu/) . . . . A.J. Demetris and Charles Richert
9:00 Discussion
9:05 Pathology image transmission over the Internet . . . . Yukako Yagi
9:20 Discussion
9:25 Plan of the Meeting from a Renal Perspective . . . . Lorraine C. Racusen
9:35 Plan of the Meeting from a Liver Perspective . . . . A. J. Demetris
9:45 Current Status of Heart Transplant Pathology (and Lessons There from!) TBA
9:50 Current Status of Lung Transplant Pathology . . . . Samuel A. Yousem
10:00 Coffee Break
10:20 The Banff Schema Six Years Later: Experience from International Clinical Trials of New Anti-rejection Agents . . . . . Kim Solez
10:40 Discussion
10:45 The 1995 Efficacy Endpoints Conference Group, The role of the Banff classification in clinical immunosuppression trials . . . . Lillian Gaber
11:00 Discussion
11:05 Early risk factors for allograft failure . . . . Peter Nickerson
11:25 Discussion
11:30 Significance of "subclinical rejection" with implications for therapy . . . . David Rush
11:55 Discussion
12:00 The UK-wide study of the Banff Schema and A Neural Network Approach . . . . Peter Furness
12:25 Discussion
12:30 Box Lunch in Poster Area - Baron Shaughnessy Ballroom
Afternoon Plenary Session - Conference Centre Theatre - Chair - Lorraine Racusen
2:00 Further studies of the clinical value of the Banff system for renal allograft pathology . . . . S. Olsen, H.E. Hansen, M. Madsen
2:15 Discussion
2:20 The CCTT scoring system . . . . Robert B. Colvin
2:35 Discussion
2:40 Significance of eosinophils and neutrophils in renal allografts . . . . John Papidimitriou
2:55 Discussion
3:00 HLA-DR and C4D: Useful diagnostic and prognostic markers in renal transplants? . . . . Michael Mihatsch
3:25 Discussion
3:30 Coffee Break
Basic Science Session - Molecular Mechanisms of Rejection Phil Halloran and Pekka Hayry, Chairs
3:50 Molecular mechanisms of acute rejection with therapeutic targets . . . . Phil Halloran
4:10 Immunopathogenesis of acute rejection . . . . Robert B. Colvin
4:30 Mechanisms of T-cell mediated killing: The Hole Story is not the Whole Story. . . . . Chris Bleakley
4:50 Discussion
5:00 Molecular mechanisms of chronic rejection with therapeutic targets . . . . Pekka Hayry
5:20 The analogy between chronic rejection and atherosclerosis . . . . Stephen M. Schwartz
5:40 Integrin adhesion molecules, vascular ligands and extracellular matrix in acute and chronic rejection . . . . Daniel Salomon
6:00 Discussion
6:15 Return to posters - Baron Shaughnessy Ballroom
7:30 Dinner
Sunday, 09 March, 1997
Conference Centre Theatre - Renal Presentations I - Larry Hunsicker - Chair
8:00 a.m. Scanning electron microscopy of tubular pole abnormalities in chronic rejection . . . . Ian Gibson
8:15 Discussion
8:20 Macrophages and thromboxane synthetase in acute rejection . . . . Byron Croker
8:35 Discussion
8:40 Reproducibility of chronic rejection scoring using the Banff schema . . . . Niels Marcussen
8:55 Discussion
9:00 Kidney Working Session - Kim Solez - Chair
12:00 Lunch
1:30 p.m. Baron Shaughnessy Ballroom
- Liver Presentations and Working Session - Jake Demetris - Chair
R. Lee - Application of the Banff Schema for acute liver allograft rejection: how does it work in practice?
S. Hubscher - Current issues on Chronic liver allograft rejection
K. Batts - Impact of HCV infection on liver allograft histology and rejection: the NIDDK experience
7:00 Dinner
Monday, 10 March, 1997
8:00 a.m. Baron Shaughnessy Ballroom
- Liver Working Session - Jake Demetris - Chair
L. Petrovic - The problem of HCV infection overlapping with rejection
A.J. Demetris - Reliability of the histopathological diagnosis of chronic rejection: results of an inter-institutional study
J. Fung - Clinical aspects of chronic rejection, including overlap with HCV infection.
12:00 Lunch
1:00 p.m. Conference Centre Theatre
- Special minisymposium on PTLD - M. Nalesnik, M.D., Chair
1:00 Glauco Frizzera, M.D.: Pathology and pathogenesis of posttransplant lymphoproliferative disorders: a historical perspective.
1:30 Margaret L. Gulley, M.D.: Epstein-barr virus and posttransplant lymphoproliferative disease. Clinical and molecular aspects.
2:00 Steven H. Swerdlow, M.D.: Summary of Society of Hematopathology workshop on posttransplant lymphoproliferative disorders.
2:30 Daniel M. Knowles, M.D.: Molecular aspects of posttransplant lymphoproliferative disorders.
3:00 Break
3:15 Cinthia Drachenberg, M.D.: Early onset PTLD in recipients of kidney-pancreas grafts
3:45 Jorge Reyes, M.D.: Treatment approaches to posttranslant lymphoproliferative disease.
7:00 p.m. Baron Shaughnessy Ballroom
- PTLD Slide Review with box supper
Tuesday, 11 March, 1997
Conference Centre Theatre - Renal Presentation II - Dan Salomon - Chair
8:00 a.m. The Simulect trials in renal transplantation - TBA
8:20 Discussion
8:30 Renal biopsies in the military - The need for Banff-like scoring in native kidney biopsies - TBA
8:50 Discussion
9:00 Kidney Working Session - Kim Solez - Chair
12:00 Lunch
1:00 p.m. Baron Shaughnessy Ballroom
- Liver Working Session - Jake Demetris - Chair
8 p.m. Farewell Banquet
Wednesday, 12 March, 1997
8:00 a.m. Conference Centre Theatre
- Manuscript discussion - led by Drs. Solez, Racusen, Demetris, Halloran, and Nalesnik
Departure or skiing
(Thursday 13 March, Friday 14 March CCTAT meeting chaired by Larry Hunsicker)
| Copyright © 1991 - 2006 Banff Conferences on
Allograft Pathology All rights reserved.
Last Modified: February 24, 1997 2:50:43 PM |
michele.hales@ualberta.ca |